WeVote
Log In

Bill

Bill

HB 2225

RELATING TO HEALTH.

2026 Regular Session Introduced by Della Belatti and 12 co-sponsors

HB 2225 advances through Hawaii legislature as unspecified health-related proposal; early referral to health and consumer protection committees limits current impact assessment.

Referred to HLT, CPC, referral sheet 5
#beneficiaries #costsharing #deductibles #pass-throughpricing #pharmacybenefitmanagers #prescriptiondrugbenefitplans #providers #reimbursement #spreadpricing
0
WeVote Research Nonpartisan
Bill Summary · HB 2225

Legislative bill overview

HB 2225 is a Hawaii health-related bill currently in early legislative stages that was introduced on January 28, 2026, and referred to the Health (HLT) and Consumer Protection (CPC) committees. The bill's specific provisions are not publicly detailed in the available information, making a complete assessment of its scope and impact difficult at this preliminary stage.

Why is this important

Health legislation in Hawaii can affect healthcare access, insurance requirements, public health initiatives, or consumer protections for the state's residents. The bill's referral to both health and consumer protection committees suggests it may address issues spanning medical regulation, patient rights, or healthcare delivery standards.

Potential points of contention

  • Lack of transparency at this stage: The bill summary is unavailable, making it impossible to identify specific stakeholder concerns or policy disagreements without the full text
  • Committee jurisdiction overlap: Referral to both HLT and CPC suggests potential jurisdictional questions or cross-cutting policy issues that committees may debate differently
  • Missing legislative details: Without knowing the bill's specific provisions, sponsors' intent, or fiscal impact, substantive analysis of contentious elements cannot be conducted

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.